Effects of (-)-menthol on arylamine N-acetyltransferase activity in human liver tumor cells

被引:10
作者
Lin, JP [1 ]
Li, YC [1 ]
Lin, WC [1 ]
Hsieh, CL [1 ]
Chung, JG [1 ]
机构
[1] China Med Coll, Dept Pharmacol, Taichung 400, Taiwan
来源
AMERICAN JOURNAL OF CHINESE MEDICINE | 2001年 / 29卷 / 02期
关键词
D O I
10.1142/S0192415X01000344
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
To evaluate whether or not (-)-menthol affects arylamine N-acetyltransferase (NAT) activity, we selected human liver tumor cell tine (J 5) for examination. By using high performance liquid chromatography, NAT activity for acetylation of 2-aminofluorene (AF) was determined. (-)Menthol displayed a dose-dependent inhibition to cytosolic NAT activity. Time-course experiments showed that NAT activity measured from intact human liver tumor cells was inhibited by (-)-menthol for up to 24 hrs. But in human liver tumor intact cells, the low doses (0.0032 and 0.032 mM) of (-)-menthol promoted the NAT activity and the high doses (3.2 and 32 mM) of (-)-menthol inhibited NAT activity and the 0.32 mM (-)-menthol did not show any significant differences between control and (-)-menthol treated groups. Using standard steady-state kinetic analysis, it was demonstrated that (-)-menthol was a possible uncompetitive inhibitor (decrease Km and Vmax) to NAT activity in cytosols. This report is the first demonstration which showed (-)-menthol affect on human liver tumor cells NAT activity.
引用
收藏
页码:321 / 329
页数:9
相关论文
共 24 条
[1]   HUMAN ARYLAMINE N-ACETYLTRANSFERASE GENES - ISOLATION, CHROMOSOMAL LOCALIZATION, AND FUNCTIONAL EXPRESSION [J].
BLUM, M ;
GRANT, DM ;
MCBRIDE, W ;
HEIM, M ;
MEYER, UA .
DNA AND CELL BIOLOGY, 1990, 9 (03) :193-203
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]  
CARTWRIGHT RA, 1982, LANCET, V2, P842
[4]  
CHUNG JG, 1993, DRUG METAB DISPOS, V21, P1057
[5]  
CLELAND WW, 1967, ADV ENZYMOL RAMB, V29, P1
[6]   MUTAGENICITY OF 30 CHEMICALS IN SALMONELLA-TYPHIMURIUM STRAINS POSSESSING DIFFERENT NITROREDUCTASE OR O-ACETYLTRANSFERASE ACTIVITIES [J].
EINISTO, P ;
WATANABE, M ;
ISHIDATE, M ;
NOHMI, T .
MUTATION RESEARCH, 1991, 259 (01) :95-102
[7]  
EVANS DAP, 1989, PHARMACOL THERAPEUT, V42, P157
[8]  
GRANT DM, 1991, MOL PHARMACOL, V39, P184
[9]  
ILETT KF, 1987, CANCER RES, V47, P1466
[10]  
LANG NP, 1994, CANCER EPIDEM BIOMAR, V3, P675